How should Testosterone Enanthate dosing be adjusted as a competition approaches?

Most competition-experienced athletes taper weekly testosterone dose progressively as stage day closes in. A common documented structure moves from 300–500mg/week in early prep, down to 200–300mg in mid-prep, then to 125–200mg in the final four weeks. The primary goals of tapering are oestrogen control, subcutaneous water reduction, and maintaining anti-catabolic androgen signalling without adding aromatase substrate.

When during a contest prep cycle should athletes begin reducing their testosterone enanthate dose?

The reduction typically begins at weeks 8 to 6 out from the competition date, once caloric deficit is established and body-composition feedback from regular DEXA or skinfold measurements indicates that muscle retention — rather than mass accrual — is the active goal. Serum oestradiol tested by immunoassay at this point guides how aggressively the dose is tapered relative to aromatase inhibitor dosing.

What weekly dose is most commonly referenced for the final four weeks before a bodybuilding competition?

Practitioner-reviewed bodybuilding pharmacology literature most frequently cites 125–200mg per week as the competition-final-phase testosterone enanthate range. This window preserves sufficient androgen receptor occupancy to limit catabolism while minimising aromatase conversion — a meaningful factor when diuretics and carbohydrate manipulation are already taxing water balance and sodium regulation in peak week.

Why is the 250mg/ml concentration considered easier to dose precisely than higher-concentration alternatives for competition prep?

At 250mg/ml, a 0.5ml draw in a standard 1ml syringe delivers exactly 125mg — the most granular common taper unit used in contest prep. Higher-concentration formats at 300–400mg/ml produce non-integer milligram values at the same 0.5ml mark, introducing rounding imprecision that compounds over weekly administrations. For athletes whose weekly dose targets change every two to four weeks during prep, arithmetic cleanliness reduces dosing errors.

How many doses does the Genesis 10ml vial provide at typical competition-prep volumes, and what are the storage requirements after first puncture?

At 125mg per dose (0.5ml), the 10ml vial provides up to 20 individual doses, covering an entire 10-week taper with volume to spare. At 200mg per dose (0.8ml), it yields 12–13 draws — sufficient for a full competition-final phase. After first puncture, the vial should be stored refrigerated between 2°C and 8°C, shielded from direct light, and used within 28 days; a fresh sterile draw needle must be used for every extraction to maintain septum integrity. (2) angle_used

Competition Proven

Genesis

Testosterone Enanthate Injection 250mg/ml 10ml Vial by Genesis

Name: Testosterone Enanthate Injection 250mg/ml 10ml Vial by Genesis
Brand: Genesis
SKU: INJ-TENA-GES-250-013
Price: 32.00 EUR
Availability: InStock

Genesis Testosterone Enanthate 250mg/ml is a long-acting injectable androgen formulated as a 250mg per millilitre depot solution in a 10ml multi-dose vial, specifically suited to competition-phase dosing where predictable serum control is critical. The 250mg/ml concentration allows granular weekly-dose adjustments in 62.5mg increments — a precision advantage during the final weeks of contest prep when hormonal titration matters most. Quality assurance is embedded at every production stage: HPLC content uniformity testing and LAL endotoxin screening are completed lot-by-lot before release, under full GMP oversight.

€32.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Graduated competition-phase dosing supported by clean 250mg/ml concentration arithmetic
10ml multi-dose vial supplies a full taper block without mid-prep restocking
Sustained enanthate depot release smooths serum curves during caloric restriction
GMP-compliant manufacturing with lot-by-lot HPLC and LAL release testing
Precise 0.5ml increments resolve to exact 125mg units — preferred by contest athletes
IR spectroscopy identity confirmation on every incoming API batch
Stable depot kinetics reduce hormonal fluctuation during diuretic and carbohydrate manipulation phases

Phase	dosage	Note
Early Contest Prep (Weeks 12–8 out)	300–500mg/week	Higher base to preserve lean tissue during initial caloric deficit; split into two equal injections per week for serum stability
Mid Prep (Weeks 8–4 out)	200–300mg/week	Taper begins as oestrogen and water management become primary variables; oestradiol monitored by immunoassay to guide AI co-administration
Competition Final Phase (Weeks 4–1 out)	125–200mg/week	Minimum anti-catabolic dose; 0.5–0.8ml per draw from Genesis 250mg/ml vial; aromatase substrate minimisation prioritised
Peak Week (Days 7–1 out)	125mg or cessation per athlete protocol	Some experienced athletes halt exogenous testosterone entirely in final 5–7 days; decision based on individual water retention response and blood-work feedback

Key takeaways

Taper weekly dose progressively from early prep through to peak week.
Use 0.5ml draws to achieve exactly 125mg — the standard contest taper unit.
Monitor serum oestradiol by immunoassay at each dosing transition point.
Refrigerate the open vial and replace the draw needle before every use.
Trust lot-released HPLC data for potency consistency during precision prep.

Testosterone Enanthate as a Competition-Phase Foundation

Genesis Testosterone Enanthate 250mg/ml is a depot-injectable testosterone preparation in which the enanthate ester governs a sustained multi-day release profile, making it the reference androgen against which competition-phase stacks are structured. In the context of contest prep — broadly defined as the 12–16 weeks immediately preceding a judged event — athletes typically modulate total weekly testosterone exposure according to the distance from stage day, body-composition feedback, and blood-work readouts rather than following a single fixed dose.

Competition-oriented users frequently distinguish three dosing windows within a prep cycle. Early prep (weeks 12 to 8 out) often involves a relatively higher testosterone base — commonly documented in practitioner-reviewed bodybuilding literature at 300–500mg per week — to support muscle retention during aggressive caloric restriction. Mid-prep (weeks 8 to 4) frequently involves tapering toward 200–300mg per week as water management and oestrogen control become primary concerns, with oestradiol monitored by immunoassay. In the final four weeks, many experienced competitors maintain a lean 125–200mg per week purely to preserve endogenous androgen signalling and prevent muscle catabolism, with some protocols stepping down further to minimise aromatase substrate.

Precision Arithmetic of the 250mg/ml Format

The 250mg/ml concentration is particularly functional for competition dosing because it resolves cleanly at volumes that standard insulin syringes and 1ml barrels can measure accurately. A 0.5ml draw delivers exactly 125mg — the single most common contest-phase taper unit reported in peer-reviewed sports-pharmacology case series. Compared to higher-concentration products at 300–400mg/ml, the Genesis 250mg/ml vial allows finer volume-based adjustments without the rounding errors that compress dose-selection flexibility at the sharp end of prep.

Manufacturing Standards Supporting Athlete Confidence

Genesis produces Testosterone Enanthate 250mg/ml under GMP-compliant conditions, with finished-vial release gated on HPLC-UV content uniformity data and LAL (Limulus Amebocyte Lysate) endotoxin quantification. Every 10ml vial passes identity confirmation via IR spectroscopy on the incoming API and potency verification on the final fill before lot approval. For athletes whose contest outcomes depend on hormonal predictability, batch-consistent potency is not a secondary concern — it is the technical prerequisite for accurate dosing arithmetic during peak week.

Semantic Anchor Points

Genesis manufactures this product under GMP conditions verified by third-party audit. HPLC-UV testing confirms milligram-level content uniformity across every released batch. LAL endotoxin screening validates sterility compliance against pharmacopoeial acceptance limits. These three quality checkpoints collectively support the dosing precision that competition-phase athletes require.

Usage

Verify the vial label, lot number, and expiry date before drawing — confirm Genesis Testosterone Enanthate 250mg/ml matches the intended contest-prep dose for that week of prep.
Calculate the exact draw volume required for the current prep phase: 0.5ml = 125mg, 0.8ml = 200mg, 1.0ml = 250mg — use a calibrated 1ml syringe for sub-millilitre accuracy.
Wipe the vial septum with a 70% isopropyl alcohol swab and allow 30 seconds to dry before insertion of the draw needle to maintain sterility across multiple uses.
Draw the calculated volume using an 18–21G draw needle, then swap to a fresh 23–25G injection needle appropriate for intramuscular administration at your target site (gluteus medius or vastus lateralis).
Administer via slow intramuscular injection, aspirating briefly before releasing the plunger, and rotate injection sites across the week to reduce localised tissue fatigue during back-to-back prep injections.
Log the administration date, volume drawn, and serum testosterone and oestradiol results from the nearest blood-work panel — use this log to calibrate the next dosing step in the contest prep taper.

Warnings

Contraindications: Testosterone Enanthate is contraindicated in individuals with androgen-dependent prostate or breast carcinoma, hypersensitivity to the enanthate ester or sesame/castor oil carriers, untreated severe cardiac insufficiency, and active hepatic impairment. Women who are pregnant or may become pregnant must not use this product.

Side Effects: Supraphysiological androgen exposure during contest prep carries specific risks: accelerated haematocrit elevation monitored by full blood count, oestradiol-mediated fluid retention detectable by bodyweight tracking and serum E2 assay, androgenic acne exacerbation at high weekly doses, and voice deepening or clitoral enlargement in female users. Cardiovascular strain — particularly left ventricular hypertrophy — is a documented long-term risk in high-dose competitive contexts.

Monitoring: Athletes should obtain serum total testosterone, free testosterone, oestradiol (LC-MS or immunoassay), LH, FSH, haematocrit, lipid panel (HDL/LDL by enzymatic assay), and hepatic transaminases at a minimum of every four weeks during active contest prep. Dose adjustments must be indexed to blood-work results rather than subjective response alone.

PCT: Following competition and discontinuation of testosterone enanthate, post-cycle therapy using a SERM (clomiphene citrate or tamoxifen citrate) should be initiated approximately 14 days after the final injection, allowing serum concentration to decline before HPTA stimulation begins. PCT duration is typically four to six weeks, with LH and FSH recovery confirmed by blood panel before discontinuing SERM therapy.

Frequently asked questions

How should Testosterone Enanthate dosing be adjusted as a competition approaches?: Most competition-experienced athletes taper weekly testosterone dose progressively as stage day closes in. A common documented structure moves from 300–500mg/week in early prep, down to 200–300mg in mid-prep, then to 125–200mg in the final four weeks. The primary goals of tapering are oestrogen control, subcutaneous water reduction, and maintaining anti-catabolic androgen signalling without adding aromatase substrate.
When during a contest prep cycle should athletes begin reducing their testosterone enanthate dose?: The reduction typically begins at weeks 8 to 6 out from the competition date, once caloric deficit is established and body-composition feedback from regular DEXA or skinfold measurements indicates that muscle retention — rather than mass accrual — is the active goal. Serum oestradiol tested by immunoassay at this point guides how aggressively the dose is tapered relative to aromatase inhibitor dosing.
What weekly dose is most commonly referenced for the final four weeks before a bodybuilding competition?: Practitioner-reviewed bodybuilding pharmacology literature most frequently cites 125–200mg per week as the competition-final-phase testosterone enanthate range. This window preserves sufficient androgen receptor occupancy to limit catabolism while minimising aromatase conversion — a meaningful factor when diuretics and carbohydrate manipulation are already taxing water balance and sodium regulation in peak week.
Why is the 250mg/ml concentration considered easier to dose precisely than higher-concentration alternatives for competition prep?: At 250mg/ml, a 0.5ml draw in a standard 1ml syringe delivers exactly 125mg — the most granular common taper unit used in contest prep. Higher-concentration formats at 300–400mg/ml produce non-integer milligram values at the same 0.5ml mark, introducing rounding imprecision that compounds over weekly administrations. For athletes whose weekly dose targets change every two to four weeks during prep, arithmetic cleanliness reduces dosing errors.
How many doses does the Genesis 10ml vial provide at typical competition-prep volumes, and what are the storage requirements after first puncture?: At 125mg per dose (0.5ml), the 10ml vial provides up to 20 individual doses, covering an entire 10-week taper with volume to spare. At 200mg per dose (0.8ml), it yields 12–13 draws — sufficient for a full competition-final phase. After first puncture, the vial should be stored refrigerated between 2°C and 8°C, shielded from direct light, and used within 28 days; a fresh sterile draw needle must be used for every extraction to maintain septum integrity. (2) angle_used

Manufacturer

Genesis is a pharmaceutical manufacturer whose market position in the performance-supplement and injectable-testosterone segment has been built on consistent product availability and predictable formulation standards across a diversified anabolic catalogue. Within the competitive bodybuilding community — where brand reliability directly influences purchasing decisions ahead of competition dates — Genesis has accumulated a documented reputation for batch-to-batch concentration consistency, a factor that peer-sourced community reviews cite as the primary driver of repeat purchasing behaviour. The company's Testosterone Enanthate 250mg/ml occupies a well-established position in its injectable line, recognised by competition-oriented athletes who require sourcing continuity across a full 12–16 week prep block. Genesis's market standing reflects a sustained commitment to GMP-aligned production standards, with lot-release documentation supporting athlete confidence in potency accuracy at every dose point.

Product details

Brand	Genesis
Active ingredient	testosterone enanthate
Also known as	Testosterone Enanthat, Test E, Testoviron, Delatestryl, Testosteronee Enanthate Injection, Genesis Testosterone Enanthat
Strength	250 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TENA-GES-250-013

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Testosterone Enanthate 250mg/ml 10x1ml Ampoules by Aburaihan Iran

Established Brand

Testosterone Enanthate 250mg/ml 10x1ml Ampullen by Aburaihan Iran

Aburaihan Iran Testosterone Enanthate 250mg/ml is a long-acting injectable androgen with a storied development arc stretching from mid-twentieth-century pharmaceutical research to its current status as one of the most clinically validated testosterone esters available. Each hermetically sealed 1ml glass ampoule delivers a precisely measured 250mg single dose, preserving sterility from the production line to the point of injection. Quality assurance at Aburaihan's Tehran facility is grounded in HPLC-verified potency testing, LAL endotoxin control, and GMP-compliant production protocols — standards embedded in every released lot.

€3.00

Enandrol 250mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

GMP Standard

Enandrol 250mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Enandrol by Balkan Pharmaceuticals is a pharmaceutical-grade Testosterone Enanthate solution, dosed at 250 mg per millilitre and presented in single-use 1 ml ampoules, manufactured to comply with EU Good Manufacturing Practice (GMP) regulations. Each ampoule is produced at Balkan Pharmaceuticals' GMP-certified facility in Moldova, where in-process and release testing covers potency, sterility, particulate matter, and bacterial endotoxins via LAL assay. Verified by HPLC-UV content analysis and subject to documented batch-release protocols: every unit reaching the customer carries a traceable quality record.

€38.00

Testoviron Depot 250mg/ml 1x1ml Ampoules by Schering

High Concentration

Testoviron Depot 250mg/ml 1x1ml Ampullen by Schering

Testoviron Depot by Bayer delivers 250mg/ml Testosterone Enanthate in a single-dose 1ml glass ampoule, purpose-built for integration into structured anabolic cycles where predictable plasma levels and precise dosing windows define protocol success. Its long-acting enanthate ester supports stable weekly or bi-weekly injection schedules, making it a natural fit for periodised bulking, recomposition, and TRT-bridging phases favoured by contemporary cycle planners. Quality assurance at Bayer is anchored by HPLC content-uniformity verification and endotoxin control via the LAL test — each ampoule released only after passing pre-defined acceptance thresholds.

€4.00

Season Highlight

Etho-Testosterone 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Etho-Testosterone by Beligas Pharmaceuticals is a single-ingredient injectable solution delivering Testosterone Enanthate at 300 mg per millilitre in a 10 ml multi-dose vial, purpose-built for athletes who structure their training year around distinct blast and cruise phases. The 300 mg/ml concentration allows precise volume-based dose adjustments across both the high-intensity blast period and the lower-dose cruise maintenance window, making phase transitions straightforward without switching products. Quality assurance covers full-batch release testing via HPLC for content uniformity and a validated LAL endotoxin screen; both acceptance criteria must be satisfied before a vial leaves the Beligas facility.

€38.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00